Guest Blog

28 11, 2023

The Business Judgement Rule and the Entire Fairness Standard As It Applies to Controlling Stockholders

By |2023-11-28T08:47:48-06:00November 28, 2023|@PLUS, D&O, Guest Blog, PL Insurance|0 Comments

Directors owe a duty of loyalty to their company and its stockholders. That duty requires that a director act in good faith and in the best interests of the company and stockholders, rather than in the director’s own interests or in the interests of someone to whom the director is beholden, controlled by, or otherwise dependent upon.[i]  Courts employ up to two standards of review when assessing challenged business transactions: the business judgment rule; or the entire fairness standard.  Paramount to the outcome of the challenge is the standard under which a director’s actions are reviewed.  If the court finds [...]

14 11, 2023

Derivative Actions: Decoding Shareholder Litigation for D&O Professionals

By |2023-11-14T08:55:45-06:00November 14, 2023|@PLUS, D&O, Guest Blog, PL Insurance|0 Comments

Your Guide to Governing Derivative Claims Greg Markel, along with his colleagues, Gina Ferarri, and Sarah Fedner have penned an incredible, comprehensive resource aimed at enriching your knowledge of governance and derivative claims - the Derivative Actions Flipbook. This guide is designed to be a valuable asset for you, your colleagues, and all stakeholders with an interest in the corporate landscape. Navigating Shareholder Advocacy: Derivative actions, lawsuits initiated by shareholders on behalf of a harmed corporation, have grown in prominence. This makes it crucial for various stakeholders, including Directors, Officers, shareholders, insurers, employees, creditors, suppliers, and financial advisors, to gain [...]

10 10, 2023

AI in Healthcare: Risks and Benefits for Medical Professional Liability

By |2023-10-12T09:14:10-05:00October 10, 2023|@PLUS, Guest Blog, Med PL|0 Comments

It is no exaggeration to state that artificial intelligence (AI) will transform health care delivery globally. In fact, it will revolutionize health care over the next decade. The amount of money invested in AI by health care organizations has grown exponentially in recent years. It was estimated to be $15.4b in 2022 and expected to continue to grow annually at 37.5% compounded annually from 2023 to 2030.1 2 For the first time in history, providers will be able to apply all medical knowledge, including the most recent studies, for the benefit of individual patients in tailoring personalized care.3 Artificial intelligence [...]

Go to Top